CD44E tumor specific antibody
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 26, 2013
Grant Date -
Dec 20, 2007
app pub date -
Jun 10, 2005
filing date -
Jun 10, 2004
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides the amino acid and nucleic acid sequences of heavy chain and light chain complementarity determining regions of a tumor specific antibody. In addition, the invention provides tumor-specific antibodies and immunoconjugates comprising the tumor-specific antibody attached to a toxin or label, and methods and uses thereof. The invention also relates to diagnostic methods and kits using the tumor-specific antibodies of the invention.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully